Medtronic (2M6.DE) Stock Analysis & Winston Score
Medtronic makes medical devices — tools and machines that doctors use to treat patients. Its products include pacemakers (devices that help hearts beat correctly), insulin pumps for people with diabetes, spinal implants, and surgical robots. Hospitals and clinics around the world are its main customers, making Medtronic one of the largest medical device companies on the planet. Medtronic earns money by selling its devices and the disposable supplies that go with them, creating repeat purchases over time. It operates in over 150 countries, with roughly half its revenue coming from outside the United States. Its main competitive advantages are decades of clinical data, deep relationships with surgeons, and a large portfolio of FDA-approved products that take years and billions of dollars for rivals to replicate. The key risk the company faces is slower-than-expected adoption of newer products, like its surgical robotics system, which it needs to grow in order to offset pricing pressure in its older, more mature device categories.
Winston Score: 58/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (19/30)
- Growth: Good (12/20)
- Cash Flow: Exceptional (9/10)
- Stability: Strong (8/10)
- Valuation: Strong (7/10)
- Ownership: Weak (1/15)
Key Facts
Price: €79.66
Market Cap: €102.0B
Sector: Healthcare
Industry: Medical - Specialties
Exchange: Frankfurt Stock Exchange

